TNNT2
EstablishedCardiac troponin T is clinically equivalent to troponin I as a gold-standard heart attack diagnostic biomarker.
Troponin T works the same way as troponin I for diagnosing heart attacks — hospitals typically use one or the other as their standard test, not both. Tracking how the level changes over a few hours, not just a single number, is often what really confirms whether a heart attack is happening right now.
TNNT2 encodes cardiac troponin T, the other of the two current gold-standard biomarkers (with troponin I) for diagnosing myocardial injury and heart attacks.
Elevated cardiac troponin T indicates myocardial injury, interpreted identically to troponin I within the universal definition of myocardial infarction; the two troponins (T and I) are generally considered clinically interchangeable for diagnostic purposes, though a given hospital typically uses one or the other, not both routinely.
As with troponin I, high-sensitivity troponin T assays use the assay-specific 99th percentile as the diagnostic threshold, with 0/1-hour or 0/3-hour rapid algorithms in wide clinical use; the same lack of a universal cutoff and need for sex-specific reference limits applies equally here.
Serial (delta) troponin T measurements distinguish acute from chronic myocardial injury, since a rising or falling pattern over serial draws indicates an acute process, while a stable elevated level suggests chronic structural heart disease rather than an acute event.
Serial (delta) measurements help distinguish acute from chronic myocardial injury patterns.
- AAFP. (2024). High-Sensitivity Troponin in the Diagnosis of Acute Coronary Syndrome.